CAS No. 267243-28-7
| IUPAC Name | N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide | |
|---|---|---|
| CAS Number | 267243-28-7 | |
| Molecular Formula |
C24H25ClFN5O3 |
|
| Molecular Weight (MW) | 485.94 | |
| SMILES | C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4 | |
| InChIKey | OMZCMEYTWSXEPZ-UHFFFAOYSA-N |
Canertinib (CI-1033) is an orally bioavailable, irreversible pan-ErbB receptor tyrosine kinase inhibitor that selectively targets EGFR, HER2, and ErbB4 over non-ErbB family kinases. By covalently binding to the ErbB receptor family, Canertinib blocks autophosphorylation and downstream activation of the AKT and MAPK signaling pathways, ultimately leading to suppression of cellular proliferation and induction of apoptosis in ErbB-expressing cancer cells. [1][2]
|
Concentration
Volume
Mass
|
|---|
| Solvent | Solubility & Note |
|---|---|
| 4-Methylpyridine | 100 mg/mL |
| DMSO |
Insoluble
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.) |
| Water | Insoluble |
| Ethanol | 22 mg/mL |
| DMSO |
2 mg/mL
(4.11 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.) |
| Water | Insoluble |
| Ethanol | 9 mg/mL |
| DMSO |
2 mg/mL
(4.11 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.) |
| Water | Insoluble |
| Ethanol | 9 mg/mL |
| DMSO |
4 mg/mL
(8.23 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.) |
| Water | Insoluble |
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Pre-aliquoted for Longevity: Solid-state aliquots offer significantly longer shelf life compared to stock solutions, ensuring maximum stability for every use.
Looking for a specific aliquot size? Reach out to your local sales representative or contact us at orders@selleckchem.com.
- Canertinib (CI-1033) Clinical Trials
- Canertinib (CI-1033) Solubility in DMSO
- Canertinib (CI-1033) Stock Solution
- Canertinib (CI-1033) Storage
- Canertinib (CI-1033) Stability
- Canertinib (CI-1033) Molecular Weight
- Canertinib (CI-1033) SMILES
- Canertinib (CI-1033) Chemical Structure (2D and 3D)
- Canertinib (CI-1033) SDS|MSDS